Should We Enter a New Market?
in Insurance Brokers

The short answer

Carrier commission share is the measurable half. Transfer of renewal accounts and risk-control data is the half that decides whether the broker clears the margin hurdle. The version of this question that applies to insurance brokers is not the generic one. 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points — so an answer that ignores 19.0 will be confidently wrong. The analysis has to start from 91.2 and 664 rather than from revenue.

Market size in new lines is calculated from available premium, yet the outcome hinges on whether the current book of renewals moves with the broker or whether new fee accounts must be originated while the 71 percent carrier flow stays intact.

A segment showing strong captive feasibility can still reduce margin if the broker cannot move existing renewal retention and standard commission relationships; shifting even 8 percent to fees requires replacing 142 accounts and lowers margin by 1.8 to 2.3 points on the 47.8 million dollar revenue base.

The CFO requires an explicit stop threshold on renewal retention or contingent commission contribution before any spend begins, because incremental outlays on risk-control staffing or captive setup can continue for years without visible impact on the 19.0, 91.2, 664 or 31 metrics.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ The deck to the CFO opens with total addressable premium and growth curves and contains no table showing how many existing renewal accounts would transfer.
✓ No document records the renewal retention rate or margin point at which the initiative is halted.
✓ The weekly commission report shows standard commissions flat and the new line is listed as the line item intended to close the gap.

The move that usually makes it worse. Entering to offset flat carrier commissions, which diverts attention from protecting retention on the accounts already generating the 71 percent flow.

Who this is for — and who it is not

It is for you if you run or finance an insurance broker and the case rests mainly on market size and growth rate. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on an insurance broker. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Kesterline Risk Partners, a sample company profile used for testing rather than a customer — 47.8 million dollars in total revenue from commissions and fees.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Market Entry & Expansion Strategy, one of 29 engagements the platform runs. For insurance brokers it works through 19.0, 91.2, 664 and 31, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

How do I judge right to win?

List what you already own that the new market values, and what a credible incumbent there owns that you do not. If the second list is longer and includes anything structural — distribution, regulation, data depth — entry is a build, not an extension.

How long should a market entry take to pay back?

Set the number before you start, and treat exceeding it as the kill criterion rather than as a reason to invest more. Most failed entries were never killed, only slowly starved.

Is it better to expand geographically or into a new segment?

Whichever reuses more of what you already have. Geography usually reuses the product and rebuilds distribution; a new segment usually reuses distribution and rebuilds the product. Whichever rebuild is smaller is the safer bet.

Is this different in insurance brokers than in other industries?

Materially, yes. 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 19.0, 91.2, 664, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for an insurance broker?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 19.0 and 91.2. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.